Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06968611

Improving Patient-centered Care for Diabetes in Bangladesh Through "Dynamic Integration" of Vision Care on the Demand Side

The goal of this clinical trial is to determine whether there is an increase in participant uptake of diabetes mellitus (DM) and diabetic retinopathy (DR) services and improved quality of patient-centered diabetic care resulting from the use of automated voice message reminders to sensitize people with DM about the potential for sight loss alongside the provision of free reading glasses.

The main questions it aims to answer are:

1. Will the proportion of patients completing their scheduled DR and DM appointments within 3 weeks of the scheduled date be significantly increased in the group receiving the automated voice messages containing both appointment reminders and messaging about the importance of visit and medication compliance in reducing the risk of vision loss, compared with participant messages which only remind them of their appointments? 2. What is the cost-effectiveness, measured as total intervention cost per additional patient complying with the suggested exam?

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Diabetes Mellitus Cardiovascular Diseases Diabetes Complications Diabetic Angiopathies Diabetic Retinopathy Diabetic Retinopathy (DR) Endocrine System Diseases Eye Diseases Glucose Metabolism Disorders Metabolic Diseases Nutritional and Metabolic Diseases Retinal Diseases Vascular Diseases

Age range

30 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Gausul Azam BNSB Eye Hospital, Dinajpur, Bangladesh

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Diagnosed with DM within the last 6 months
  • Over 30 years of age
  • Currently treated at the Dinajpur Diabetes Hospital
  • Possess a mobile phone to receive voice messages
  • Willingness to participate in the study, and ability to give informed consent

Exclusion criteria

  • Other significant causes of vision loss
  • Medical conditions that could impair compliance with follow-up (such as stroke, dementia, etc.)

Treatment and study plan

Education/information of risk

Other

Participant will receive a message underscoring risk of vision loss from poorly controlled DM, and how this risk can be largely eliminated with excellent compliance with mediations and clinical visits.

Free eye glasses

Other

Participants will receive a free pair of reading glass at their first appointment

Primary outcomes

  1. Proportion of patients completing their diabetes or DR exam within 3 weeks of the scheduled date.

    Time frame: 3 weeks following scheduled exam date

Secondary outcomes

  1. Cost-effectiveness, measured as total intervention cost per additional patient adherence with the suggested exam.

    Time frame: Enrollment to 3 weeks following suggested exam date

Study contacts

Contact information is provided by the study sponsor or research team.

Lutful Husain

CONTACT

[email protected]

+88 01711626852

Nathan Congdon

CONTACT

[email protected]

+44 7748751393

Sponsors and collaborators

Lead sponsor

Orbis

Other

Collaborators

  • District Diabetes Hospital, Dinajpur district of Bangladesh
  • Gausul Azam BNSB Eye Hospital, Dinajpur district of Bangladesh

Registry information

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
May 13, 2025
Registry last updated
Sep 11, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.